Back to Search
WILLIAM DELANEY, MD
MD
Internal Medicine Physician
NPI: 1942387634Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
26131(CT)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
WARREN ALPERT MEDICAL SCHOOL OF BROWN UNIVERSITY
Class of 1982
Research & Publications (20)
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro.
PMID 12183271·Antimicrob Agents Chemother·2002
8-other
Evolving therapies for the treatment of chronic hepatitis B virus infection.
PMID 11829711·Expert Opin Investig Drugs·2002
6-review
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
PMID 11437320·Antivir Chem Chemother·2001
4-observational
Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.
PMID 11353615·Antimicrob Agents Chemother·2001
8-other
Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors.
PMID 19477126·Bioorg Med Chem Lett·2009
7-preclinical
Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virus.
PMID 19457562·Antiviral Res·2009
4-observational
Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates.
PMID 19063924·Antiviral Res·2009
8-other
Therapy of chronic hepatitis B: trends and developments.
PMID 18835366·Curr Opin Pharmacol·2008
6-review
In vitro drug susceptibility analysis of hepatitis B virus clinical quasispecies populations.
PMID 17687019·J Clin Microbiol·2007
8-other
In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.
PMID 17591025·Antivir Ther·2007
8-other
Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil.
PMID 17332007·J Antimicrob Chemother·2007
8-other
In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.
PMID 17215289·J Virol·2007
7-preclinical
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.
PMID 16801428·Antimicrob Agents Chemother·2006
8-other
Antimicrobial beta-peptoids by a block synthesis approach.
PMID 16384703·Bioorg Med Chem Lett·2006
8-other
Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV.
PMID 16152756·Antivir Ther·2005
8-other
Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
PMID 15980342·Antimicrob Agents Chemother·2005
4-observational
Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients.
PMID 15655050·J Viral Hepat·2005
8-other
Combinations of adefovir with nucleoside analogs produce additive antiviral effects against hepatitis B virus in vitro.
PMID 15388423·Antimicrob Agents Chemother·2004
8-other
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
PMID 15302140·Antiviral Res·2004
7-preclinical
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.
PMID 15188170·Gastroenterology·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 70 MAIN ST
DANBURY, CT 06810 - Phone
- (203) 791-5030
Quick Facts
- NPI
- 1942387634
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Publications
- 20
Are you this provider?
Claim Your Profile